Jillian Clare Kohler
Affiliation: University of Toronto
- Why the MDGs need good governance in pharmaceutical systems to promote global healthJillian Clare Kohler
Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto M5S 3 M2, ON, Canada
BMC Public Health 14:63. 2014..This discussion on the pharmaceutical system illuminates why...
- "To patent or not to patent? the case of Novartis' cancer drug Glivec in India"Ravinder Gabble
Associate Professor and Director Global Health, Leslie Dan Faculty of Pharmacy, and Munk School of Global Affairs, University of Toronto, 144 College Street, Toronto, Ontario M5S 3 M2, Canada
Global Health 10:3. 2014..Indeed, the Supreme Court stated that even if the bioavailability of the drug was improved, it did not demonstrate enhanced efficacy and that Glivec was not patentable...
- Corruption in the health care sector: A barrier to access of orthopaedic care and medical devices in UgandaMaryse Bouchard
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
BMC Int Health Hum Rights 12:5. 2012..abstract:..
- An examination of pharmaceutical systems in severely disrupted countriesJillian Clare Kohler
Associate Professor, Leslie Dan Faculty of Pharmacy and Munk School of Global Affairs, University of Toronto, Toronto, Canada
BMC Int Health Hum Rights 12:34. 2012..Counterfeit and sub-standard medicines trade networks have also developed. To help increase medicine availability for citizens, informal markets should be integrated into existing access to medicines initiatives...
- Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines RegimeLaura C Esmail
Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada
BMC Int Health Hum Rights 10:1. 2010..The purpose of this study was to examine how the media framed CAMR to determine how policy goals were conceptualized, which stakeholder interests controlled the public debate and how these variables related to the public policy process...
- Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groupsDella Kwan
1Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Canada
BMC Complement Altern Med 8:40. 2008..In this paper, consumers' and practicing pharmacists' perceptions of pharmacists' professional responsibilities with respect to NHPs are examined...
- Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standardsJillian Clare Cohen-Kohler
Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
Health Econ Policy Law 3:229-56. 2008....
- The morally uncomfortable global drug gapJ C Cohen-Kohler
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
Clin Pharmacol Ther 82:610-4. 2007..2, 3) But governments also have to ensure that the policy environment is supportive of access to medicines. And this includes making sure that social policy is not undercut by economic interests...
- The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug accessLaura C Esmail
Leslie Dan Faculty of Pharmacy, Toronto, ON, Canada
Global Health 8:7. 2012..Since it was passed in 2004, only two orders of antiretroviral drugs, enough for 21,000 HIV/AIDS patients in Rwanda have been exported. Future use of the regime appears unlikely. This research aimed to examine the politics of CAMR...
- The use of cost-effectiveness analysis for pediatric immunization in developing countriesCindy Low Gauvreau
St Michael s Hospital, Toronto, Canada
Milbank Q 90:762-90. 2012..Cost-effectiveness analysis (CEA) is a tool that decision makers can use for efficiently allocating expanding resources. Its use in developing countries, however, lags behind that in industrialized countries...
- The make or buy debate: considering the limitations of domestic production in TanzaniaKinsley Rose Wilson
Leslie Dan Faculty of Pharmacy and Munk School of Global Affairs, University of Toronto, 144 College Street, Toronto, M5S 3M2, Canada
Global Health 8:20. 2012..In order for domestic manufacturing to be viable and cost-effective, the local industry must be able to compete with international suppliers of medicines by producing sufficiently low cost ARVs...